Cost Spirals for US Victims of Cyberfraud

Joseph Menn, Financial Times
Monday, 15 Mar 2010 | 10:16 AM ET

Online fraud cases in the US cost victims more than twice as much in 2009 as they did the previous year, underscoring fears that internet crime is growing out of control.

The Federal Bureau of Investigation’s Internet Crime Complaint Center, a web portal the US law enforcement agency operates in conjunction with the National White Collar Crime Center, last year referred cases involving total losses of $560m (€407m, £368m) for investigation by various authorities – up from $265m in 2008 and $183m five years ago.

The FBI gave no indication of how much money had been recovered, but US Federal Trade Commission officials have said that a large majority of serious internet crime is committed from overseas, especially eastern Europe, where enforcement is difficult.

Donald Brackman, white collar crime centre director, said cybercriminals were “developing increasingly sophisticated means of defrauding unsuspecting consumers. Internet crime is evolving in ways we couldn’t have imagined just five years ago”.

The FBI said the portal referred twice as many complaints for enforcement in 2009, a record 127,000, as it did in 2008. Non-delivery of promised goods or services triggered the most referrals for enforcement, followed by identity theft and credit or debit card fraud.

The FBI figures do not include complaints to local police or other agencies.


Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Mad Money's Jim Cramer discusses Micron Technology and how the company gained control over inventory issues. The bears expect the company's history to repeat itself, but Cramer says this time, it feels different.

  • In this excerpt from a live CNBC interview, Warren Buffett explains why it's extremely unusual for a company's directors to vote against executive compensation plans.

  • Mad Money host Jim Cramer says shareholder activism works for every shareholder, and offers his take on the Valeant/Bill Ackman bid to acquire Allergan. The market is better off for these efforts, he says.